Head and Neck

Print
PDF

USO 10025 A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER (RTOG 0920)

Please contact the NYOH Research Department for more information on clinical trials at (518) 489-0044 ext. 1239